San Jose, California, United States / 29 December 2022 – Complete Genomics Inc, a subsidiary of MGI Tech Co., Ltd., today announced that it will present at Biotech Showcase™ 2023 in San Francisco, coinciding with the JP Morgan Healthcare Conference. Registered attendees can view the presentation live or on-demand if scheduling does not allow viewing during the main event week.
Complete Genomics provides comprehensive high-throughput sequencing instrumentation and related products, including sample extraction, library preparation, automation systems, sequencing platforms and bioinformatics. Rade Drmanac, PhD, Chief Scientific Officer, will provide an overview of the complete suite of instruments and products.
- Date: Monday, 9 January 2023
- Time: 16:30 PST
- Venue: Hilton San Francisco Union Square Hotel
- Room: Franciscan D
“Dating back as early as 2006, we have been at the forefront of life science innovation and continue to redefine sequencing possibilities through our innovative DNBSEQ™ technology,” said Dr Drmanac. “Our massively parallel sequencing (MPS) and sample processing automation products have empowered countless researchers worldwide. At Biotech Showcase™ we will demonstrate how our enhanced sequencing capabilities can help partners accelerate breakthroughs in life science and healthcare.”
Complete Genomics sequencing platforms combine DNBSEQ™, sample extraction, library preparation, automation systems and bioinformatics. In August 2022, the DNBSEQ-G400C* sequencer launched in the US with immediate adoption in customer labs and partnerships with life science companies.
Additionally, Complete Genomics will launch the “Empowerment Program America” at Biotech Showcase, collaborating with researchers to develop grant proposals and expand sequencing choice.
About Biotech Showcase
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference designed to advance therapeutic development through a sophisticated networking platform for executives and investors. The event features presenting companies, plenary sessions, workshops, networking and one-to-one meetings. Now in its 15th year, it attracts investors and biopharmaceutical executives from around the world.
“We are delighted that Complete Genomics will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “The conference is an ideal platform for life science entrepreneurs and investors to explore innovative technologies that will shape the future of drug discovery.”
About Complete Genomics
Complete Genomics, a subsidiary of MGI Tech Co., Ltd., is a global life science company offering lab automation and a comprehensive high-throughput sequencing portfolio. Founded in June 2005 and headquartered in San Jose, California, the company operates a demo lab and supply centre with sequencers and lab automation equipment on display. Its first next-generation sequencing system, the DNBSEQ-G400C* platform, launched in the US in August 2022. For full specifications, visit the Complete Genomics website.
Contacts
Shani Lewis
Assistant Vice President, Media
LaVoieHealthScience
(617) 865-5554
slewis@lavoiehealthscience.com
Dada Zhang
Senior Public Relations Manager
MGI Tech / Complete Genomics
zhangling8@mgi-tech.com
Follow Complete Genomics on Twitter at @CompleteGenomics and Biotech Showcase at @EBDGroup and @Demy_Colton. Tag posts with #BiotechShowcase.
*Unless otherwise stated, StandardMPS and CoolMPS sequencing reagents and compatible sequencers are not available in Germany, Spain, UK, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, Austria or Romania. StandardMPS reagents and compatible sequencers are not available in Hong Kong. No purchase orders for StandardMPS products will be accepted in the USA until after 1 January 2023.
*Products are for research use only. Not for diagnostic procedures.
